Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Vyluma, Inc.

Home Clinical Trial Sponsors and OrganizationsVyluma, Inc.

Vyluma, Inc.

ACTIVE

New Jersey, United Statesvyluma.comPrivate

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

4

2 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

2

50.0%

Phase 3

2

50.0%

Trial Status Distribution

Active, not recruiting

2

50.0%

Completed

2

50.0%

Clinical Trials

Trials sponsored by this organization (4)

Study of slowing progression (worsening) of school myopia (short-sightedness) in children by testing very low dose atropine eye drops against placebo eye drops (drops without atropine).

Active, not recruiting

Jun 2018483 participants

Study of slowing progression (worsening) of school myopia (short-sightedness) in children by testing very low dose atropine eye drops against placebo eye drops (drops without atropine).

Active, not recruiting

May 2018483 participants

CHAMP: Study of NVK-002 in Children With Myopia

Nov 2017670 participants

Childhood Atropine for Myopia Progression (CHAMP): A 3-Arm Randomized, Double-Masked, Placebo-Controlled, Phase 3 Study of Atropine Sulfate Ophthalmic Solution 0.01% and 0.02%

40 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials4
Approvals
News

Back to Organizations